← Fresenius Medical Care AG
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $16.6b |
$17.8b
+7.33%
|
$16.5b
-6.95%
|
$17.5b
+5.62%
|
$17.9b
+2.19%
|
$17.6b
-1.35%
|
$19.4b
+10.10%
|
$19.5b
+0.29%
|
$19.3b
-0.61%
|
$19.6b
+1.51%
|
$19.4b
-1.02%
|
|
| Revenue From Interest | — | — | $141.5m | $59.4m | $41.1m | $52.9m | $56.4m | $124.8m | $69.0m | $68.0m | — | |
| Cost of Goods and Services Sold | $11.0b |
$11.8b
+7.54%
|
$11.4b
-3.29%
|
$12.1b
+6.04%
|
$12.3b
+1.99%
|
$12.5b
+1.79%
|
$14.1b
+12.33%
|
$14.5b
+3.13%
|
$14.6b
+0.35%
|
$14.6b
+0.13%
|
$14.3b
-2.00%
|
|
| Gross Profit (derived) | $5.6b |
$6.0b
+6.90%
|
$5.2b
-14.14%
|
$5.4b
+4.68%
|
$5.5b
+2.62%
|
$5.1b
-8.31%
|
$5.3b
+4.59%
|
$4.9b
-7.25%
|
$4.8b
-3.42%
|
$5.0b
+5.72%
|
$5.1b
+1.81%
|
|
| Research and development | $146.5m | $130.7m | $114.1m | $168.0m | $193.8m | $220.8m | $228.6m | $232.0m | $183.5m | $158.0m | $154.3m | |
| Selling, General and Administrative Expense | $3.1b | $3.6b | $2.9b | $3.1b | $3.2b | $3.1b | $3.8b | $3.2b | $3.1b | $3.0b | $3.0b | |
| Operating expenses: | ||||||||||||
| Interest Expense | — | — | $438.0m | $486.0m | $407.1m | $343.8m | $359.0m | $420.9m | $393.3m | $375.2m | $383.0m | |
| Interest Expense On Lease Liabilities | — | — | — | $171.7m | $159.1m | $143.2m | $151.3m | $148.8m | $148.4m | $143.2m | $383.0m | |
| Other Income | — | — | — | — | — | — | — | $515.2m | $760.1m | $528.1m | — | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $58.6m | $67.2m | $73.3m | $73.7m | $94.5m | $92.2m | $66.6m | $121.8m | $134.9m | $181.4m | — | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | ($10.9m) | ($203.0m) | $89.2m | $64.3m | $111.1m | $67.3m | ($41.5m) | ($122.1m) | ($72.7m) | ($27.2m) | — | |
| Income Tax Expense Continuing Operations | $622.5m | $454.0m | $511.1m | $401.6m | $500.6m | $352.8m | $325.0m | $300.6m | $316.1m | $321.0m | $314.2m | |
| Basic Earnings (Loss) Per Share | $3.74 | $4.17 | $6.47 | $3.96 | $3.96 | $3.31 | $2.30 | $1.70 | $1.83 | $3.36 | $1.66 | |
| Diluted Earnings (Loss) Per Share | $3.73 | $4.16 | $6.45 | $3.96 | $3.96 | $3.31 | $2.30 | $1.70 | $1.83 | $3.36 | $1.66 | |
| Additional Financial Items | ||||||||||||
| Applicable Tax Rate | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Auditors Remuneration For Tax Services | $164k | $830k | $1.1m | $318k | — | — | $1.2m | — | — | $23k | — | |
| Average Effective Tax Rate | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Depreciation And Amortisation Expense | — | — | $724.8m | $1.6b | $1.6b | $1.6b | $1.7b | $1.6b | $1.5b | $1.5b | — | |
| Depreciation Right of Use Assets | — | — | — | $700.3m | $704.0m | $690.5m | $746.5m | $700.7m | $675.5m | $647.6m | — | |
| Employee Benefits Expense | $6.3b | $6.9b | $6.4b | $6.8b | $7.1b | $7.0b | $7.9b | $7.8b | $7.8b | $7.7b | — | |
| Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used | — | — | — | $25.2m | $27.4m | $23.2m | $17.4m | $22.2m | $20.1m | $14.2m | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | — | $52.1m | $49.5m | $44.9m | $52.4m | $59.3m | $53.1m | $65.2m | — | |
| Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities | — | — | — | $10.8m | $12.4m | $12.2m | $13.8m | $10.5m | $6.3m | $2.8m | — | |
| Finance Costs | $408.5m | $397.2m | $448.5m | $491.1m | $410.0m | $353.6m | $360.1m | $424.6m | $407.0m | $384.4m | — | |
| Finance Income | $42.1m | $43.3m | $147.4m | $61.6m | $42.0m | $73.2m | $67.7m | $88.2m | $71.6m | $69.6m | — | |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | — | — | — | $38.3m | $119.6m | $139.2m | $206.7m | $37.0m | — | |
| Other Employee Expense | $1.3b | $1.5b | — | — | — | — | — | — | — | — | — | |
| Postemployment Benefit Expense Defined Benefit Plans | $134.6m | $147.3m | $38.5m | $39.2m | $50.1m | $48.8m | $53.8m | $55.6m | $52.4m | $47.1m | — | |
| Postemployment Benefit Expense Defined Contribution Plans | $43.8m | $48.7m | — | — | — | — | — | — | — | — | — | |
| Profit Loss Attributable To Noncontrolling Interests | $276.1m | $274.7m | $243.7m | $238.9m | $271.5m | $249.7m | $220.9m | $233.5m | $203.0m | $212.9m | — | |
| Profit Loss Attributable To Owners Of Parent | $1.1b | $1.3b | $2.0b | $1.2b | $1.2b | $969.3m | $673.4m | $499.0m | $537.9m | $978.4m | — | |
| Profit Loss Before Tax | $2.0b | $2.0b | $2.7b | $1.8b | $1.9b | $1.6b | $1.2b | $1.0b | $1.1b | $1.5b | — | |
| Profit Loss From Operating Activities | $2.4b | $2.4b | $3.0b | $2.3b | $2.3b | $1.9b | $1.5b | $1.4b | $1.4b | $1.8b | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.